Skip to main content
Karen Bloch, MD, Infectious Disease, Nashville, TN

Karen Bloch MD

Infectious Disease•Nashville, TN

Associate Professor, Medicine, Vanderbilt University School of Medicine

Join to view full profile

  • 3601 21st Ave SNashville, TN 37232

  • Phone+1 615-322-3000

  • Fax+1 615-936-0605

Dr. Bloch is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Bloch's full profileAlready have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Infectious Disease, 1994 - 1997
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1990 - 1993
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1995 - Present
  • KY State Medical License
    KY State Medical License 2019 - 2027
  • TN State Medical License
    TN State Medical License 1997 - 2027
  • CT State Medical License
    CT State Medical License 1993 - 1994
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification StarPanel, Vanderbilt University, 2012, 2014-2017
  • CMS Meaningful Use Stage 2 Certification BI-Clinical, CitiusTech, Inc., 2012, 2014-2017
  • CMS Meaningful Use Stage 2 Certification StarPanel, Vanderbilt University, 2012, 2014-2017

Publications & Presentations

PubMed

Press Mentions

  • Monoclonal Antibody Treatments Scarce After Two Versions Found to Be Ineffective Against Omicron
    Monoclonal Antibody Treatments Scarce After Two Versions Found to Be Ineffective Against OmicronDecember 28th, 2021
  • State Health Officials from Tennessee Plan to Limit Monoclonal Antibody Treatment to Only Unimmunized Individuals
    State Health Officials from Tennessee Plan to Limit Monoclonal Antibody Treatment to Only Unimmunized IndividualsSeptember 24th, 2021
  • Tennessee Restricting Monoclonal Immunizer Treatment to Unvaccinated Occupants
    Tennessee Restricting Monoclonal Immunizer Treatment to Unvaccinated OccupantsSeptember 22nd, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Karen Bloch, Dr. Karen Bloch, MD, Dr. K Bloch